Billionaires Holding GALT

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 22.1M
    Shares Outstanding

  • 94.0M
    Market Cap

News & Insights

ABOUT

GALT

Galectin Therapeutics Inc. is a drug development company. The Company creates new therapies for fibrotic disease and cancer using its carbohydrate technology that targets galectin proteins which are key mediators of biologic and pathologic functions. Gelectin uses naturally occurring carbohydrat...

Hedge funds hate Apple ... but love Facebook

NEWS

BRIEF-Berkshire Hathaway buys about 824,000 shares of Phillips 66

READ MORE